Cereno Scientific AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	-0.29	-	-	-	-	-
Revenue	-0.29	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
Gross Profit	-0.29	-	-	-	-	-
Selling, General & Admin	193.58	117.74	154.5	89.9	84.12	59.57
Other Operating Expenses	-113.37	-44.27	-80.9	-45.68	-57.54	-44.81
Operating Expenses	81	74.25	73.88	44.24	26.6	14.78
Operating Income	-81.29	-74.25	-73.88	-44.24	-26.6	-14.78
Interest Expense	-45.01	-44.55	-26.09	-5.3	-0.46	-1.25
Interest & Investment Income	1.4	1.4	2.4	1.84	0.31	0
Currency Exchange Gain (Loss)	-0.35	-0.35	-1.96	-0.41	-0.9	-0.23
Pretax Income	-125.25	-117.75	-99.53	-48.11	-27.65	-16.25
Income Tax Expense	-	-	-	-	0.01	0
Net Income	-125.25	-117.75	-99.53	-48.11	-27.65	-16.25
Net Income to Common	-125.25	-117.75	-99.53	-48.11	-27.65	-16.25
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	308	296	282	234	138	105
Shares Outstanding (Diluted)	308	328	309	234	138	105
Shares Change	8.44%	6.11%	32.25%	70.00%	30.64%	44.58%
EPS (Basic)	-0.41	-0.40	-0.35	-0.21	-0.20	-0.15
EPS (Diluted)	-0.41	-0.40	-0.35	-0.21	-0.20	-0.15
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-52.79	-112	-107.29	-36.92	-18.62	-13.14
Free Cash Flow Per Share	-0.17	-0.34	-0.35	-0.16	-0.14	-0.13
EBITDA	-80.5	-73.47	-73.59	-44.22	-26.58	-14.77
D&A For EBITDA	0.79	0.79	0.29	0.01	0.01	0.01
EBIT	-81.29	-74.25	-73.88	-44.24	-26.6	-14.78
Revenue as Reported	113.2	44.27	80.9	49.28	57.54	44.81